Want to join the conversation?
$CELG said that the company expects continuing flow of data for Otezla in 2016. In the coming year and beyond the company expects a steady stream of mid stage and proof of concept data to begin to establish the clinical profiles of a number of molecules generated from distributed and integrated research and drug development model.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?